Research indicates rgp 160 provides long-term immunologic protection. Chimpanzee resists HIV challenge more than two years after vaccination.
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control*; D000818:Animals; D004353:Drug Evaluation, Preclinical; D015686:Gene Products, env / Q000276:immunology*; D019302:HIV Envelope Protein gp160; D002679:Pan troglodytes; D011498:Protein Precursors / Q000276:immunology*; D014765:Viral Vaccines / Q000627:therapeutic use*
D015686:Gene Products, env; D019302:HIV Envelope Protein gp160; D011498:Protein Precursors; D014765:Viral Vaccines